Evolving Brand-Name and Generic Drug Competition May Warrant a Revision of the Hatch-Waxman Act

Health Affairs, 2011, 30(11), 2157-2166

View article

Authors

Grabowski HG, Kyle M, Mortimer R, Long G, Kirson N